Abstract

To The Editor:
W
As a database study with little clinical information per individual, these results are very difficult to interpret. Of particular note is the 40% of events designated “cardiovascular disease not otherwise specified.” Are these events of clinical relevance? We also note that 57% had had a dose reduction within the previous 12 months. Given the concern regarding the cardiac safety of stimulant medication, it is vital that the rate of adverse cardiovascular events be accurately estimated, preferably by medical record review (Cooper et al. 2011), and distinguished from the known sympathomimetic effects of stimulant medication (tachycardia, transient hypertension). Useful information from the databases that could help to identify genuine pathology would be repeated use of the same ICD code. The authors need to provide the number and diagnostic breakdown of those who have scored an ICD-10 cardiac diagnosis on more than one occasion.
Footnotes
Disclosures
No competing financial interests exist.
